Compounds > salicylaldehyde isonicotinoyl hydrazone
Page last updated: 2024-08-21

salicylaldehyde isonicotinoyl hydrazone and daunorubicin

salicylaldehyde isonicotinoyl hydrazone has been researched along with daunorubicin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamcová, M; Gersl, V; Guncová, I; Kaiserová, H; Mazurová, Y; Palicka, V; Ponka, P; Popelová, O; Potácová, A; Simůnek, T; Sterba, M1
Adamcová, M; Čajnáková, H; Gersl, V; Hrbatová, L; Ponka, P; Popelová, O; Potáčová, A; Šimůnek, T; Sterba, M1
Adamcová, M; Gersl, V; Hasková, P; Hroch, M; Kaiserová, H; Ponka, P; Popelová, O; Simůnek, T; Sterba, M1

Other Studies

3 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and daunorubicin

ArticleYear
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
    Toxicology, 2007, Jun-25, Volume: 235, Issue:3

    Topics: Aldehydes; Animals; Cells, Cultured; Daunorubicin; Heart Diseases; Heart Ventricles; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Myocytes, Cardiac; Rabbits; Rats; Troponin T

2007
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
    Physiological research, 2007, Volume: 56, Issue:2

    Topics: Aldehydes; Animals; Cardiomyopathies; Cardiotonic Agents; Chronic Disease; Daunorubicin; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Heart Conduction System; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Pyridoxal; Rabbits; Razoxane; Time Factors; Troponin T

2007
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
    British journal of pharmacology, 2008, Volume: 155, Issue:1

    Topics: Aldehydes; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Cell Proliferation; Cell Survival; Cytoprotection; Daunorubicin; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Lipid Peroxidation; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Time Factors

2008